Tris(2-hydroxypropane-1,2,3-tricarboxylic acid);phosphoric acid;7H-purine
C23H31N4O25P — CID 159643932
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tris(2-hydroxypropane-1,2,3-tricarboxylic acid);phosphoric acid;7H-purine
Tris(2-hydroxypropane-1,2,3-tricarboxylic acid);phosphoric acid;7H-purine (PubChem CID 159643932) has the molecular formula C23H31N4O25P and a molecular weight of 794.48 g/mol. Its IUPAC name is tris(2-hydroxypropane-1,2,3-tricarboxylic acid);phosphoric acid;7H-purine.
Molecular Properties
| Compound Name | Tris(2-hydroxypropane-1,2,3-tricarboxylic acid);phosphoric acid;7H-purine |
|---|---|
| PubChem CID | 159643932 |
| Molecular Formula | C23H31N4O25P |
| Molecular Weight | 794.48 g/mol |
| Exact Mass | 794.10 |
| IUPAC Name | tris(2-hydroxypropane-1,2,3-tricarboxylic acid);phosphoric acid;7H-purine |
| SMILES | O=C(O)CC(O)(CC(=O)O)C(=O)O.O=C(O)CC(O)(CC(=O)O)C(=O)O.O=C(O)CC(O)(CC(=O)O)C(=O)O.O=P(O)(O)O.c1ncc2[nH]cnc2n1 |
| InChI | InChI=1S/3C6H8O7.C5H4N4.H3O4P/c3*7-3(8)1-6(13,5(11)12)2-4(9)10;1-4-5(8-2-6-1)9-3-7-4;1-5(2,3)4/h3*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);1-3H,(H,6,7,8,9);(H3,1,2,3,4) |
| InChIKey | MQSCILPFJIVQQB-UHFFFAOYSA-N |
| XLogP | -4.32 |
| TPSA | 528.61 Ų |
| H-Bond Donors | 16 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 15 |
| Heavy Atoms | 53 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 794.48 |
| LogP ≤ 5 | -4.32 |
| H-Bond Donors ≤ 5 | 16 |
| H-Bond Acceptors ≤ 10 | 16 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phosphor', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159643932 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.